Aveanna Healthcare (NASDAQ:AVAH) Cut to Hold at Zacks Research

Zacks Research cut shares of Aveanna Healthcare (NASDAQ:AVAH) from a strong-buy rating to a hold rating in a report issued on Monday,Zacks.com reports.

A number of other equities analysts have also recently issued reports on AVAH. Truist Financial lowered their price objective on shares of Aveanna Healthcare from $6.00 to $5.00 and set a “hold” rating for the company in a research report on Wednesday, July 16th. Weiss Ratings restated a “hold (c)” rating on shares of Aveanna Healthcare in a research report on Wednesday, October 8th. Jefferies Financial Group upgraded shares of Aveanna Healthcare from a “hold” rating to a “buy” rating and decreased their price target for the company from $6.25 to $6.00 in a research report on Monday, July 21st. JPMorgan Chase & Co. upgraded shares of Aveanna Healthcare from an “underweight” rating to a “neutral” rating and upped their price target for the company from $6.00 to $10.00 in a research report on Thursday, September 18th. Finally, Wall Street Zen upgraded shares of Aveanna Healthcare from a “buy” rating to a “strong-buy” rating in a research report on Saturday, August 9th. Three research analysts have rated the stock with a Buy rating and five have issued a Hold rating to the company’s stock. According to data from MarketBeat.com, the stock presently has an average rating of “Hold” and an average price target of $8.08.

Aveanna Healthcare Trading Down 7.3%

Shares of Aveanna Healthcare stock opened at $9.48 on Monday. The company has a 50 day moving average of $8.41 and a 200-day moving average of $6.09. Aveanna Healthcare has a 1-year low of $3.67 and a 1-year high of $10.32. The company has a market cap of $1.98 billion, a PE ratio of 118.50 and a beta of 2.05.

Aveanna Healthcare (NASDAQ:AVAH) last issued its quarterly earnings results on Monday, May 22nd. The company reported $0.04 earnings per share for the quarter. Aveanna Healthcare had a net margin of 0.85% and a negative return on equity of 54.56%. The company had revenue of $450.53 million during the quarter. Research analysts forecast that Aveanna Healthcare will post -0.06 earnings per share for the current year.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently bought and sold shares of the stock. Banque Transatlantique SA bought a new position in Aveanna Healthcare during the first quarter worth $25,000. Quantbot Technologies LP bought a new position in shares of Aveanna Healthcare in the second quarter valued at $43,000. Diversified Trust Co bought a new position in shares of Aveanna Healthcare in the second quarter valued at $57,000. Jump Financial LLC bought a new position in shares of Aveanna Healthcare in the first quarter valued at $59,000. Finally, MQS Management LLC bought a new position in shares of Aveanna Healthcare in the second quarter valued at $59,000. 87.96% of the stock is owned by institutional investors.

About Aveanna Healthcare

Aveanna Healthcare Holdings Inc, a diversified home care platform company, provides pediatric and adult healthcare services in the United States. Its patient-centered care delivery platform allows patients to remain in their homes and minimizes the overutilization of high-cost care settings, such as hospitals or skilled nursing facilities.